Pulmuone, the South Korean food manufacturer specializing in plant-based products, is expanding its noodle business in the United States after securing high growth in Asia. The company said on Sunday, May 14, that it is planning to boost its Asian noodle production line in the country by the end of 2023.
The decision comes as the demand for the Pulmuone Asian noodle there has exploded. As per The Korea Times, the company's sales for the said product last year reached $72.2 million. This is said to be a 65% on-year growth in sales.
Moreover, in the last three years, Pulmuone's Asian noodle products in the U.S. saw a 119% growth. A company official said that the profits were mainly boosted by the bustling sales of its Asian noodle products, particularly the Teriyaki Stir-fry Udon and Tonkotsu Miso Ramen. The combined sales of these two items alone were said to have reached two million units in the first quarter.
"The company's efforts to expand the US Asian noodle market led to an almost tenfold increase in sales over the last six years, from $8.2 million in 2016 to $72.2 million in 2022," the Pulmuone official said in a statement.
The managing director of Pulmuone Foods US, Kim Suk Won, also said that the brands' entry to other markets has been successful as well. With this, they will continue growing the brand in the U.S.
"With quality taste and convenient cooking proven in the US market, Pulmuone Asian noodle products have successfully entered Canada and the UK," Kim said. "We will continue the growth momentum by launching products with various types of noodles made with Pulmuone's world-class noodle manufacturing technology."
Finally, to maintain its position in the U.S. as a fast-growing brand in the Asian noodle market, Pulmuone will complete the construction of another production plant being built at its Gilroy facility in California this year.
Photo by: Pulmuone Newsroom


Gold Prices Slip as U.S.-Iran Conflict, Fed Rate Hike Bets Pressure Precious Metals
Fed Chair Kevin Warsh Launches Task Forces to Overhaul U.S. Monetary Policy Framework
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Oil Prices Rise as U.S.-Iran Conflict Fuels Strait of Hormuz Supply Fears
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Asian Stocks Rise as AI Chip Rally Offsets Middle East Tensions
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Gold Price Rebounds as U.S.-Iran Tensions and Fed Minutes Keep Markets on Edge
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Dollar Slips After Fed Minutes as Iran Tensions, Inflation Risks Keep Markets Cautious
US Back-to-School Spending Seen Falling as Families Focus on Essentials
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 



